Congress trades
Amedisys, Inc. (AMED)
About Amedisys, Inc.
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Chief executive
- Richard M. Ashworth
- Employees
- 19,000
- Listed since
- Aug 17, 1994
- Market value
- $3.3B
- Price to earnings
- 25.8
- Earnings per share
- $3.92
- Dividend yield
- -
Earnings
6 reported quarters| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2025reported Jul 29, 2025 | $1.54 | $1.39 | $621.9M | $635.8M | EPS beatRevenue miss |
| Q1 FY2025reported Apr 23, 2025 | $1.25 | $1.13 | $594.8M | $612.0M | EPS beatRevenue miss |
| Q4 FY2024reported Feb 26, 2025 | $0.96 | $1.05 | $598.1M | $602.4M | EPS missRevenue in line |
| Q3 FY2024reported Nov 6, 2024 | $1.00 | $1.17 | $587.7M | $596.4M | EPS missRevenue in line |
| Q2 FY2024reported Jul 24, 2024 | $1.32 | $1.22 | $591.2M | $578.8M | EPS beatRevenue beat |
| Q1 FY2024reported Apr 24, 2024 | $1.03 | $1.01 | $571.4M | $565.4M | EPS beatRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in AMED
5 disclosures of 5 on record · median 25d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | n/a | Aug 18, 2025 | Sep 12, 2025 | 25d |
| Lisa C. McClainSpouseFiled late | Stock | Purchase | $1,001 - $15,000 | +7.2%S&P +7.6% · vs S&P 500 -0.4% | Jun 9, 2025 | Aug 13, 2025 | 65d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +27.9%S&P +64.7% · vs S&P 500 -36.8% | Mar 14, 2023 | Apr 7, 2023 | 24d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +4.6%S&P +58.1% · vs S&P 500 -53.5% | Feb 10, 2023 | Mar 3, 2023 | 21d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +23.9%S&P +63.1% · vs S&P 500 -39.2% | Jan 11, 2023 | Feb 7, 2023 | 27d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 6, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded AMED?
Lisa C. McClain, Ro Khanna disclosed AMED transactions in the filings shown here.
How quickly are AMED trades disclosed?
Congressional disclosures took a median of 25 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.